Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Di Lullo

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
Giornale Italiano Di Cardiologia (2006)|October 4, 2018
[Evaluation of adverse drug reactions associated with direct oral anticoagulants recorded in the Italian Pharmacovigilance Network database using a specifically developed risk index]Massimo Uguccioni, Antonio Terranova, Luca Di Lullo
Journal of Nephrology|August 6, 2021
Direct oral anticoagulants and chronic kidney disease: it is time to be braveMarco Valerio Mariani, Luca Di Lullo, Carlo Lavalle
Journal of Clinical Medicine|November 14, 2019
Chronic Kidney Disease: The Silent EpidemyAntonio Bellasi, Luca Di Lullo, Biagio Di Iorio
Atherosclerosis|February 22, 2018
Vascular inflammation: A call for a specific and sensitive biomarker?Antonio Bellasi, Luca Di Lullo, Biagio Di Iorio
International Urology and Nephrology|April 18, 2024
Finerenone in type 2 diabetic and albuminuric renal disease patients: three case reportsLuca Di Lullo, Davide Salera, Cristina Galderisi, et al.
Kardiologia Polska|May 8, 2024
Cardiovascular screening in chronic kidney disease subjects waiting for transplantation: Unresolved questionAntonio Bellasi, Davide Salera, Carlo Ratti, et al.
Reviews in Cardiovascular Medicine|September 26, 2021
Cardionephrology and cardiorenal disease in Italy: state of the artLuca Di Lullo, Antonio Bellasi, Vincenzo Barbera, et al.
International Urology and Nephrology|July 2, 2024
Correction to: Finerenone in type 2 diabetic and albuminuric renal disease patients: three case reportsLuca Di Lullo, Davide Salera, Cristina Galderisi, et al.
Cardiorenal Medicine|April 12, 2012
Low-Dose Treatment with Erythropoiesis-Stimulating Agents and Cardiovascular Geometry in Chronic Kidney Disease: Is Darbepoetin-α More Effective than Expected?Luca Di Lullo, Fulvio Floccari, Antonio Granata, et al.
Medicina|September 5, 2014
[Twinkling artifact on color Doppler in nephrolithiasis]Rodolfo F Rivera, Fulvio Floccari, Franco Logias, et al.
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Giornale Italiano Di Cardiologia (2006)|October 4, 2018
[Evaluation of adverse drug reactions associated with direct oral anticoagulants recorded in the Italian Pharmacovigilance Network database using a specifically developed risk index]Massimo Uguccioni, Antonio Terranova, Luca Di Lullo
Journal of Nephrology|August 6, 2021
Direct oral anticoagulants and chronic kidney disease: it is time to be braveMarco Valerio Mariani, Luca Di Lullo, Carlo Lavalle
Journal of Clinical Medicine|November 14, 2019
Chronic Kidney Disease: The Silent EpidemyAntonio Bellasi, Luca Di Lullo, Biagio Di Iorio
Atherosclerosis|February 22, 2018
Vascular inflammation: A call for a specific and sensitive biomarker?Antonio Bellasi, Luca Di Lullo, Biagio Di Iorio
International Urology and Nephrology|April 18, 2024
Finerenone in type 2 diabetic and albuminuric renal disease patients: three case reportsLuca Di Lullo, Davide Salera, Cristina Galderisi, et al.
Kardiologia Polska|May 8, 2024
Cardiovascular screening in chronic kidney disease subjects waiting for transplantation: Unresolved questionAntonio Bellasi, Davide Salera, Carlo Ratti, et al.
Reviews in Cardiovascular Medicine|September 26, 2021
Cardionephrology and cardiorenal disease in Italy: state of the artLuca Di Lullo, Antonio Bellasi, Vincenzo Barbera, et al.
International Urology and Nephrology|July 2, 2024
Correction to: Finerenone in type 2 diabetic and albuminuric renal disease patients: three case reportsLuca Di Lullo, Davide Salera, Cristina Galderisi, et al.
Cardiorenal Medicine|April 12, 2012
Low-Dose Treatment with Erythropoiesis-Stimulating Agents and Cardiovascular Geometry in Chronic Kidney Disease: Is Darbepoetin-α More Effective than Expected?Luca Di Lullo, Fulvio Floccari, Antonio Granata, et al.
Medicina|September 5, 2014
[Twinkling artifact on color Doppler in nephrolithiasis]Rodolfo F Rivera, Fulvio Floccari, Franco Logias, et al.
Pageof 13